Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidance on Requirements for QTc Measurement in ECG Monitoring When Introducing New Drugs and Shorter Regimens for the Treatment of Drug-Resistant Tuberculosis

Tool
Guidance on Requirements for QTc Measurement in ECG Monitoring When Introducing New Drugs and Shorter Regimens for the Treatment of Drug-Resistant Tuberculosis

This document describes the steps necessary to measure the corrected QT (QTc) interval from electrocardiography (ECG) monitoring for patients being treated either with the shorter treatment regimen or the new drugs for drug-resistant TB treatment.

Author:

Challenge TB Project

Topic:

Treatment- Adverse Reactions, MDR TB

View Webpage

Related Materials

Generic Programmatic and Clinical Guide for the Introduction of New Drugs and Shorter Regimen for Treatment of Multi/Extensively Drug-Resistant Tuberculosis

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

Guideline

Generic Programmatic and Clinical Guide for the Introduction of new drugs and Shorter Regimens for the Treatment of Multi/Extensively Drug-Resistant Tuberculosis

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

The Use of Bedaquiline in the Treatment of Multi-Drug Resistant Tuberculosis: Interim Policy Guidance

This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).

Guideline

Global resources for the prevention,
management, and elimination of TB.